Loading company…
Ocean Genomics develops software for gene expression analysis, biomarker discovery and drug response prediction.
Founded in 2018 and based in Pennsylvania, US, Ocean Genomics develops computational biology software for gene expression analysis and biomarker and target discovery. Its platform analyzes RNA-Seq data and mRNA changes to help predict biological responses to drugs. It offers transcriptome data, curated metadata and pre-trained AI models through TxomeAI® and DiscoverAI™. Accenture led venture funding in February 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in